Citations (74)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Chanthawat Patikorn, Warittakorn Kategeaw, Johnna Perdrizet, Xiuyan Li & Nathorn Chaiyakunapruk. (2023) Implementation challenges and real-world impacts of switching pediatric vaccines: A global systematic literature review. Human Vaccines & Immunotherapeutics 19:1.
Read now
Read now
Adriana Guzman-Holst, Eduardo Ortega-Barria, Ángel Alexis Flores, Roberto Carreño-Manjarrez, Dagna Constenla & Maria Yolanda Cervantes-Apolinar. (2021) 15-year experience with rotavirus vaccination in Mexico: a systematic literature review. Human Vaccines & Immunotherapeutics 17:10, pages 3623-3637.
Read now
Read now
Benjamin D. Hallowell, Jacqueline Tate & Umesh Parashar. (2020) An overview of rotavirus vaccination programs in developing countries. Expert Review of Vaccines 19:6, pages 529-537.
Read now
Read now
Adrienne Guignard, Nicolas Praet, Viviane Jusot, Marina Bakker & Laurence Baril. (2019) Introducing new vaccines in low- and middle-income countries: challenges and approaches. Expert Review of Vaccines 18:2, pages 119-131.
Read now
Read now
Eleanor Burnett, Jacqueline E. Tate, Carl D. Kirkwood, E. Anthony S. Nelson, Mathuram Santosham, A. Duncan Steele & Umesh D. Parashar. (2018) Estimated impact of rotavirus vaccine on hospitalizations and deaths from rotavirus diarrhea among children <5 in Asia. Expert Review of Vaccines 17:5, pages 453-460.
Read now
Read now
Lucia Helena de Oliveira, Silas Pierson Trumbo, Cuauhtémoc Ruiz Matus, N. Jennifer Sanwogou & Cristiana M. Toscano. (2016) Pneumococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned. Expert Review of Vaccines 15:10, pages 1295-1304.
Read now
Read now
Dagna Constenla & Samantha Clark. (2016) Financing dengue vaccine introduction in the Americas: challenges and opportunities. Expert Review of Vaccines 15:4, pages 547-559.
Read now
Read now
Sheng-I Chen, Bryan A. Norman, Jayant Rajgopal, Tina M. Assi, Bruce Y. Lee & Shawn T. Brown. (2014) A planning model for the WHO-EPI vaccine distribution network in developing countries. IIE Transactions 46:8, pages 853-865.
Read now
Read now
Lot Jata Nyirenda, Kristin Ingstad Sandberg & Judith Justice. (2014) When Are Health Systems Ready for New Vaccines? The Introduction of Pneumococcal Vaccine in Malawi. Forum for Development Studies 41:2, pages 317-336.
Read now
Read now
Auliya A Suwantika, Neily Zakiyah, Keri Lestari & Maarten J Postma. (2014) Accelerating the introduction of rotavirus immunization in Indonesia. Expert Review of Vaccines 13:4, pages 463-472.
Read now
Read now
Alexandre C Linhares & Maria Cleonice A Justino. (2014) Rotavirus vaccination in Brazil: effectiveness and health impact seven years post-introduction. Expert Review of Vaccines 13:1, pages 43-57.
Read now
Read now
Sai Kit Lam. (2013) Challenges in reducing dengue burden; diagnostics, control measures and vaccines. Expert Review of Vaccines 12:9, pages 995-1010.
Read now
Read now
Miguel O’Ryan, Yalda Lucero & Alexandre C Linhares. (2011) Rotarix®: vaccine performance 6 years postlicensure. Expert Review of Vaccines 10:12, pages 1645-1659.
Read now
Read now
Victoria Jiang, Baoming Jiang, Jacqueline Tate, Umesh D. Parashar & Manish M. Patel. (2010) Performance of rotavirus vaccines in developed and developing countries. Human Vaccines 6:7, pages 532-542.
Read now
Read now
Ener Cagri Dinleyici & Zafer Kurugol. (2010) 6th World Congress of the World Society for Pediatric Infectious Diseases (WSPID). Expert Review of Vaccines 9:3, pages 261-272.
Read now
Read now
Miguel O’Ryan & Alexandre C Linhares. (2009) Update on Rotarix™: an oral human rotavirus vaccine. Expert Review of Vaccines 8:12, pages 1627-1641.
Read now
Read now
Toyoko Nakagomi & Osamu Nakagomi. (2009) A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix. Expert Opinion on Biological Therapy 9:8, pages 1073-1086.
Read now
Read now
Dexiang Chen & Debra Kristensen. (2009) Opportunities and challenges of developing thermostable vaccines. Expert Review of Vaccines 8:5, pages 547-557.
Read now
Read now
Articles from other publishers (56)
Sebastian Garcia Marti, Luz Gibbons, Sara Reidel, Juan Stupka, Juan Degiuseppe, Fernando Argento & Jorge A. Gómez. (2022) Rotavirus Vaccine Impact since Its Introduction in the National Immunization Program of Argentina. Infectious Diseases and Therapy 12:2, pages 513-526.
Crossref
Crossref
Miranda J. Delahoy, César Cárcamo, Luis Ordoñez, Vanessa Vasquez, Benjamin Lopman, Thomas Clasen, Gustavo F. Gonzales, Kyle Steenland & Karen Levy. (2020) Impact of Rotavirus Vaccination Varies by Level of Access to Piped Water and Sewerage: An Analysis of Childhood Clinic Visits for Diarrhea in Peru, 2005–2015. Pediatric Infectious Disease Journal 39:8, pages 756-762.
Crossref
Crossref
Jung Min YoonTae Hwan HanSo Won YoonYong Joo KimSung Hee Oh. (2018) Changes in the Occurrence of Rotavirus Gastroenteritis before and after the Introduction of Rotavirus Vaccine among Hospitalized Pediatric Patients and Estimates of Rotavirus Vaccine Effectiveness. Pediatric Infection and Vaccine 25:1, pages 26.
Crossref
Crossref
Bruce Y. Lee & Leila A. Haidari. (2017) The importance of vaccine supply chains to everyone in the vaccine world. Vaccine 35:35, pages 4475-4479.
Crossref
Crossref
Leila A. Haidari, Shawn T. Brown, Patrick Wedlock, Diana L. Connor, Marie Spiker & Bruce Y. Lee. (2017) When are solar refrigerators less costly than on-grid refrigerators: A simulation modeling study. Vaccine 35:17, pages 2224-2228.
Crossref
Crossref
Mathuram Santosham & Duncan Steele. (2017) Rotavirus Vaccines ? A New Hope. New England Journal of Medicine 376:12, pages 1170-1172.
Crossref
Crossref
Juan I. Degiuseppe, Juan A. Stupka & Gabriel I. Parra. 2017. Human Virology in Latin America. Human Virology in Latin America
63
79
.
N. Aliabadi, J.E. Tate & U.D. Parashar. (2016) Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines. Clinical Microbiology and Infection 22, pages S128-S135.
Crossref
Crossref
Eleanor Burnett, Catherine Yen, Jacqueline E Tate & Umesh D Parashar. (2016) Rotavirus vaccines: current global impact and future perspectives. Future Virology 11:10, pages 699-708.
Crossref
Crossref
Stef Lemmens, Catherine Decouttere, Nico Vandaele & Mauro Bernuzzi. (2016) A review of integrated supply chain network design models: Key issues for vaccine supply chains. Chemical Engineering Research and Design 109, pages 366-384.
Crossref
Crossref
Umesh D. Parashar, Margaret M. Cortese, Daniel C. Payne, Benjamin Lopman, Catherine Yen & Jacqueline E. Tate. (2015) Value of Post-Licensure Data on Benefits and Risks of Vaccination to Inform Vaccine Policy. American Journal of Preventive Medicine 49:6, pages S377-S382.
Crossref
Crossref
Umesh D Parashar, Margaret M Cortese, Daniel C Payne, Benjamin Lopman, Catherine Yen & Jacqueline E Tate. (2015) Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: The example of rotavirus vaccines. Vaccine 33, pages D55-D59.
Crossref
Crossref
Ching-Min Wang, Shou-Chien Chen & Kow-Tong Chen. (2015) Current status of rotavirus vaccines. World Journal of Pediatrics 11:4, pages 300-308.
Crossref
Crossref
A.M. Ropero-Álvarez, A. Whittembury, P. Bravo-Alcántara, H.J. Kurtis, M.C. Danovaro-Holliday & M. Velandia-González. (2015) Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean. Vaccine 33:1, pages 187-192.
Crossref
Crossref
Rachel M Burke, Emily R Smith, Rebecca Moritz Dahl, Paulina A Rebolledo, Maria del Carmen Calder?n, Beatriz Ca?ipa, Edgar Chavez, Rolando Pinto, Luis Tamayo, Carlos Ter?n, ?ngel Veizaga, Remy Zumaran, Volga I?iguez & Juan S Leon. (2014) The economic burden of pediatric gastroenteritis to Bolivian families: a cross-sectional study of correlates of catastrophic cost and overall cost burden. BMC Public Health 14:1.
Crossref
Crossref
Christabel C Enweronu-Laryea, Isaac Boamah, Eric Sifah, Stanley K Diamenu & George Armah. (2014) Decline in severe diarrhea hospitalizations after the introduction of rotavirus vaccination in Ghana: a prevalence study. BMC Infectious Diseases 14:1.
Crossref
Crossref
J. E. Tate & U. D. Parashar. (2014) Rotavirus Vaccines in Routine Use. Clinical Infectious Diseases 59:9, pages 1291-1301.
Crossref
Crossref
. (2014) Enhancing the Work of the Department of Health and Human Services National Vaccine Program in Global Immunization: Recommendations of the National Vaccine Advisory Committee. Public Health Reports 129:5_suppl3, pages 12-85.
Crossref
Crossref
P. W. Espejo, F. O. Peralta, H. C. Pacheres, L. J. del Valle, A. C. Tapia, J. B. Mayra, J. Ruiz & J. del Valle Mendoza. (2014) Diarrhoea caused by rotavirus in a regional Peruvian hospital: determination of circulating genotypes. Transactions of the Royal Society of Tropical Medicine and Hygiene 108:7, pages 425-430.
Crossref
Crossref
Nicholas M. Kiulia, Martin M. Nyaga, Mapaseka L. Seheri, Marianne Wolfaardt, Walda B. van Zyl, Mathew D. Esona, Grace Irimu, Murithi Inoti, Bernard W. Gatinu, Peter K. Njenga, Maureen B. Taylor & Atunga Nyachieo. (2014) Rotavirus G and P Types Circulating in the Eastern Region of Kenya. Pediatric Infectious Disease Journal 33:Supplement 1, pages S85-S88.
Crossref
Crossref
Rachel M Burke, Paulina A Rebolledo, Sally R Embrey, Laura Danielle Wagner, Carter L Cowden, Fiona M Kelly, Emily R Smith, Volga Iñiguez & Juan S Leon. (2013) The burden of pediatric diarrhea: a cross-sectional study of incurred costs and perceptions of cost among Bolivian families. BMC Public Health 13:1.
Crossref
Crossref
Hiten D. Patel, Eric T. Roberts & Dagna O. Constenla. (2013) Cost-effectiveness of a new rotavirus vaccination program in Pakistan: A decision tree model. Vaccine 31:51, pages 6072-6078.
Crossref
Crossref
Bruce G. Weniger & Gregory M. Glenn. (2013) Cutaneous vaccination: antigen delivery into or onto the skin. Vaccine 31:34, pages 3389-3391.
Crossref
Crossref
Leila A. Haidari, Diana L. Connor, Angela R. Wateska, Shawn T. Brown, Leslie E. Mueller, Bryan A. Norman, Michelle M. Schmitz, Proma Paul, Jayant Rajgopal, Joel S. Welling, Jim Leonard, Sheng-I Chen & Bruce Y. Lee. (2013) Augmenting Transport versus Increasing Cold Storage to Improve Vaccine Supply Chains. PLoS ONE 8:5, pages e64303.
Crossref
Crossref
Terri B. Hyde, Holly Dentz, Susan A. Wang, Helen E. Burchett, Sandra Mounier-Jack & Carsten F. Mantel. (2012) The impact of new vaccine introduction on immunization and health systems: A review of the published literature. Vaccine 30:45, pages 6347-6358.
Crossref
Crossref
Tina-Marie Assi, Korngamon Rookkapan, Jayant Rajgopal, Vorasith Sornsrivichai, Shawn T. Brown, Joel S. Welling, Bryan A. Norman, Diana L. Connor, Sheng-I Chen, Rachel B. Slayton, Yongjua Laosiritaworn, Angela R. Wateska, Stephen R. Wisniewski & Bruce Y. Lee. (2012) How influenza vaccination policy may affect vaccine logistics. Vaccine 30:30, pages 4517-4523.
Crossref
Crossref
Juan A. Stupka, Juan I. Degiuseppe & Gabriel I. Parra. (2012) Increased frequency of rotavirus G3P[8] and G12P[8] in Argentina during 2008?2009: Whole-genome characterization of emerging G12P[8] strains. Journal of Clinical Virology 54:2, pages 162-167.
Crossref
Crossref
Lilly M. Verhagen, Adilia Warris, Peter W. M. Hermans, Berenice del Nogal, Ronald de Groot & Jacobus H. de Waard. (2012) High Prevalence of Acute Respiratory Tract Infections Among Warao Amerindian Children in Venezuela in Relation to Low Immunization Coverage and Chronic Malnutrition. Pediatric Infectious Disease Journal 31:3, pages 255-262.
Crossref
Crossref
Bruce Y. LeeTina-Marie AssiJayant RajgopalBryan A. NormanSheng-I ChenShawn T. BrownRachel B. SlaytonSouleymane KoneHailu KeneaJoel S. WellingDiana L. ConnorAngela R. WateskaAnirban JanaAnn E. WiringaWillem G. Van PanhuisDonald S. Burke. (2012) Impact of Introducing the Pneumococcal and Rotavirus Vaccines Into the Routine Immunization Program in Niger. American Journal of Public Health 102:2, pages 269-276.
Crossref
Crossref
Jennifer Cortes, Wences Arvelo, Beatriz Lopez, Lissette Reyes, Tara Kerin, Rashi Gautam, Manish Patel, Umesh Parashar & Kim A. Lindblade. (2011) Rotavirus disease burden among children <5 years of age – Santa Rosa, Guatemala, 2007–2009. Tropical Medicine & International Health 17:2, pages 254-259.
Crossref
Crossref
Vicente Bayard, Rodrigo DeAntonio, Rodolfo Contreras, Olga Tinajero, Maria Mercedes Castrejon, Eduardo Ortega-Barr?a & Romulo E. Colindres. (2012) Impact of rotavirus vaccination on childhood gastroenteritis-related mortality and hospital discharges in Panama. International Journal of Infectious Diseases 16:2, pages e94-e98.
Crossref
Crossref
Irene Perez Schael, Miguel O’Ryan, Xavier Sáez-Llorens, Alexandre C. Linhares, F.R. Velázquez, Romulo E. Colindres, Thomas Breuer & Eduardo Ortega-Barria. (2012) Clinical development, registration, and introduction of human rotavirus vaccine: The Latin American experience. Trials in Vaccinology 1, pages 10-20.
Crossref
Crossref
Greg L. Plosker. (2011) Rotavirus Vaccine RIX4414 (Rotarix™). PharmacoEconomics 29:11, pages 989-1009.
Crossref
Crossref
Sai Kit Lam, Donald Burke, Maria Rosario Capeding, Chee Keong Chong, Laurent Coudeville, Jeremy Farrar, Duane Gubler, Sri Rezeki Hadinegoro, Jeffrey Hanna, Jean Lang, Han Lim Lee, Yee Sin Leo, Chan Quang Luong, Richard Mahoney, John Mcbride, Jorge Mendez-Galvan, Lee Ching Ng, Suchitra Nimmannitya, Eng Eong Ooi, Donald Shepard, Jaco Smit, Rémy Teyssou, Laurent Thomas, Joseph Torresi, Pedro Vasconcelos, Dewa Nyoman Wirawan & Sutee Yoksan. (2011) Preparing for introduction of a dengue vaccine: Recommendations from the 1st Dengue v2V Asia-Pacific Meeting. Vaccine 29:51, pages 9417-9422.
Crossref
Crossref
Bruce Y. Lee, Tina-Marie Assi, Korngamon Rookkapan, Angela R. Wateska, Jayant Rajgopal, Vorasith Sornsrivichai, Sheng-I Chen, Shawn T. Brown, Joel Welling, Bryan A. Norman, Diana L. Connor, Rachel R. Bailey, Anirban Jana, Willem G. Van Panhuis & Donald S. Burke. (2011) Maintaining Vaccine Delivery Following the Introduction of the Rotavirus and Pneumococcal Vaccines in Thailand. PLoS ONE 6:9, pages e24673.
Crossref
Crossref
Ricardo Q. Gurgel, Chinenye Ilozue, Jailson B. Correia, Chiara Centenari, Sandala M. T. Oliveira & Luis E. Cuevas. (2011) Impact of rotavirus vaccination on diarrhoea mortality and hospital admissions in Brazil. Tropical Medicine & International Health 16:9, pages 1180-1184.
Crossref
Crossref
Franco Maria Ruggeri, Roberto Delogu, Tatiana Petouchoff, Olga Tcheremenskaia, Simona De Petris & Lucia Fiore. (2011) Molecular characterization of rotavirus strains from children with diarrhea in Italy, 2007-2009. Journal of Medical Virology 83:9, pages 1657-1668.
Crossref
Crossref
Geert Leroux-Roels, Paolo Bonanni, Terapong Tantawichien & Fred Zepp. (2011) Vaccine development. Perspectives in Vaccinology 1:1, pages 115-150.
Crossref
Crossref
Jon Kim AndrusBarbara JaureguiLúcia Helena De OliveiraCuauhtémoc Ruiz Matus. (2011) Challenges To Building Capacity For Evidence-Based New Vaccine Policy In Developing Countries. Health Affairs 30:6, pages 1104-1112.
Crossref
Crossref
Bruce Y. Lee, Tina-Marie Assi, Korngamon Rookkapan, Diana L. Connor, Jayant Rajgopal, Vorasith Sornsrivichai, Shawn T. Brown, Joel S. Welling, Bryan A. Norman, Sheng-I Chen, Rachel R. Bailey, Ann E. Wiringa, Angela R. Wateska, Anirban Jana, Willem G. Van Panhuis & Donald S. Burke. (2011) Replacing the measles ten-dose vaccine presentation with the single-dose presentation in Thailand. Vaccine 29:21, pages 3811-3817.
Crossref
Crossref
Greice Madeleine Ikeda do Carmo, Catherine Yen, Jennifer Cortes, Alessandra Ara?jo Siqueira, Wanderson Kleber de Oliveira, Juan Jos? Cortez-Escalante, Ben Lopman, Brendan Flannery, Lucia Helena de Oliveira, Eduardo Hage Carmo & Manish Patel. (2011) Decline in Diarrhea Mortality and Admissions after Routine Childhood Rotavirus Immunization in Brazil: A Time-Series Analysis. PLoS Medicine 8:4, pages e1001024.
Crossref
Crossref
D. H. Esposito, J. E. Tate, G. Kang & U. D. Parashar. (2010) Projected Impact and Cost-Effectiveness of a Rotavirus Vaccination Program in India, 2008. Clinical Infectious Diseases 52:2, pages 171-177.
Crossref
Crossref
Lucia Helena de Oliveira, M. Carolina Danovaro-Holliday, N. Jennifer Sanwogou, Cuauhtemoc Ruiz-Matus, Gina Tambini & Jon Kim Andrus. (2011) Progress in the Introduction of the Rotavirus Vaccine in Latin America and the Caribbean. Pediatric Infectious Disease Journal 30:1, pages S61-S66.
Crossref
Crossref
Celia D. C. Christie, Newton D. Duncan, Kirk A. Thame, Matthew T. OnoratoHyacinth D. Smith, Lavern G. Malcolm, Robbin F. Itzler, Mark J. DiNubile & Penny M. Heaton. (2010) Pentavalent Rotavirus Vaccine in Developing Countries: Safety and Health Care Resource Utilization. Pediatrics 126:6, pages e1499-e1506.
Crossref
Crossref
Keith Grimwood, Stephen B. Lambert & Richard J. Milne. (2010) Rotavirus Infections and Vaccines. Pediatric Drugs 12:4, pages 235-256.
Crossref
Crossref
Carlos Rodrigo, Nuran Salman, Vladimir Tatochenko, Zsofia Mészner & Carlo Giaquinto. (2010) Recommendations for rotavirus vaccination: A worldwide perspective. Vaccine 28:31, pages 5100-5108.
Crossref
Crossref
Maria Paulke-Korinek, Pamela Rendi-Wagner, Michael Kundi, Renate Kronik & Herwig Kollaritsch. (2010) Universal Mass Vaccination Against Rotavirus Gastroenteritis. Pediatric Infectious Disease Journal 29:4, pages 319-323.
Crossref
Crossref
Bruce Y. Lee & Donald S. Burke. (2010) Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles. Vaccine 28:16, pages 2806-2809.
Crossref
Crossref
Magaly Martínez, Alberto A. Amarilla, Maria E. Galeano, Victor H. Aquino, Norma Fariña, Graciela Russomando & Gabriel I. Parra. (2010) Predominance of rotavirus G2P[4] and emergence of G12P[9] strains in Asunción, Paraguay, 2006–2007. Archives of Virology 155:4, pages 525-533.
Crossref
Crossref
Vesta Richardson, Joselito Hernandez-Pichardo, Manjari Quintanar-Solares, Marcelino Esparza-Aguilar, Brian Johnson, Cesar Misael Gomez-Altamirano, Umesh Parashar & Manish Patel. (2010) Effect of Rotavirus Vaccination on Death from Childhood Diarrhea in Mexico. New England Journal of Medicine 362:4, pages 299-305.
Crossref
Crossref
Ricardo G. Gurgel, Anna K. Bohland, Sarah C.F. Vieira, Débora M.P. Oliveira, Paula B. Fontes, Viviane F. Barros, Marcela F. Ramos, Winifred Dove, Toyoko Nakagomi, Osamu Nakagomi, Jailson B. Correia, Nigel Cunliffe & Luis E. Cuevas. (2009) Incidence of Rotavirus and All-Cause Diarrhea in Northeast Brazil Following the Introduction of a National Vaccination Program. Gastroenterology 137:6, pages 1970-1975.
Crossref
Crossref
Donald W. Light, Jon Kim Andrus & Rebecca N. Warburton. (2009) Estimated research and development costs of rotavirus vaccines. Vaccine 27:47, pages 6627-6633.
Crossref
Crossref
Krisztián Bányai, Mathew D. Esona, Tara K. Kerin, Jennifer J. Hull, Slavica Mijatovic, Nancy Vásconez, Carlos Torres, Ana M. B. de Filippis & Jon R. Gentsch. (2009) Molecular characterization of a rare, human-porcine reassortant rotavirus strain, G11P[6], from Ecuador. Archives of Virology 154:11, pages 1823-1829.
Crossref
Crossref
Elisabeth Sanchez-Padilla, Rebecca F Grais, Philippe J Guerin, Andrew D Steele, Marie-Eve Burny & Francisco J Luquero. (2009) Burden of disease and circulating serotypes of rotavirus infection in sub-Saharan Africa: systematic review and meta-analysis. The Lancet Infectious Diseases 9:9, pages 567-576.
Crossref
Crossref
Steven BlackPatrick LF Zuber. (2009) Global trends and challenges in vaccine safety. Pediatric Health 3:4, pages 329-335.
Crossref
Crossref
Carlos G. Teran, Carlos N. Teran-Escalera & Patricia Villarroel. (2009) Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhea in children: a randomized, single-blind, controlled trial in Bolivian children. International Journal of Infectious Diseases 13:4, pages 518-523.
Crossref
Crossref